
Qingsong Health surged 94% in HK grey market.

QingSong Health will use the IPO proceeds to increase its brand visibility and market position, as well as to enhance user engagement and deepen cooperation with business partners.
China International Capital Corporation, China Merchants Securities (HK), Futu Securities International (Hong Kong), and SPDB International Capital are the joint bookrunners of the IPO.